Test Price
2,800 AED✅ Home Collection Available
ABCC9 Gene Atrial Fibrillation Type 12 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين ABCC9 للرجفان الأذيني العائلي من النوع 12 في الإمارات | 2,800 درهم إماراتي | معتمد من هيئة الصحة بدبي 2026
ملخص تنفيذي: تحليل متطور للكشف عن الطفرات الجينية في جين ABCC9 المرتبطة بالرجفان الأذيني العائلي، بدقة تشخيصية 99.9%، مع خدمات جمع العينات المنزلية المعتمدة واستشارات طبية هاتفية بعد النتائج.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Fully compliant with UAE Federal Decree-Law No. 41 of 2024 (Art. 87), CDS Law 2026 (Minors), and UAE PDPL Data Privacy.
Comprehensive Genetic Analysis for Familial Atrial Fibrillation
The ABCC9 gene encodes the SUR2 subunit of cardiac ATP-sensitive potassium channels; pathogenic variants cause autosomal dominant atrial fibrillation type 12 and are linked to cardiomyopathy. This advanced NGS test delivers definitive molecular diagnosis, guiding personalized management and family screening. (يكشف هذا التحليل الجيني عن الطفرات المسببة للرجفان الأذيني الوراثي بدقة عالية، مما يساعد في توجيه العلاج وفحص الأقارب.)
| Feature | Our Test: ABCC9 NGS | Generic Cardiac Gene Panel |
|---|---|---|
| Diagnostic Precision | >99.9% analytical sensitivity & specificity | Variable, often lower depth for ABCC9 |
| Methodology | Illumina NGS + Sanger confirmation | NGS multi‑gene, may miss deep intronic variants |
| Turnaround Time | 3–4 Weeks ISO‑Certified | 4–8 Weeks typical |
| Genetic Counselling | Mandatory pre‑ and post‑test session included | Often not provided or optional |
Physician Insight & Safety Protocol
Clinical Correlation Note from Dr. PRABHAKAR REDDY (DHA License 61713011):
“Understanding your genetic predisposition to atrial fibrillation can be empowering, yet this result is just one piece of a complex puzzle. I always interpret it in conjunction with your echocardiogram, ECG, and family history to provide the most accurate risk assessment. Please remember, no single test replaces a thorough clinical evaluation.”
⚠️ Medication Warning: Do not discontinue prescribed medication without consulting your doctor. Stopping anticoagulants or antiarrhythmics abruptly can be life‑threatening.
Exclusion Criteria & Emergency Red Flags
- Active severe infection or fever; wait until resolved.
- Known bleeding disorder or current anticoagulation with warfarin (INR > 3.0) – please discuss with phlebotomist.
- If you experience sudden chest pain, severe palpitations, dizziness, or syncope, seek immediate emergency medical attention; do not delay for genetic testing.
Frequently Asked Questions
1. What is the ABCC9 gene and its role in atrial fibrillation?
Snippet: This advanced NGS test detects ABCC9 gene mutations linked to familial atrial fibrillation type 12 with 99.9% accuracy and clinical sensitivity.
The ABCC9 gene provides instructions for making a protein that forms part of potassium channels in heart muscle; specific mutations lead to abnormal electrical signaling, causing early‑onset atrial fibrillation that often runs in families. Identifying the mutation enables targeted surveillance and management.
(جين ABCC9 ينتج بروتيناً يشكل قنوات البوتاسيوم في عضلة القلب؛ طفراته تؤدي إلى خلل في الإشارات الكهربائية مسببة الرجفان الأذيني المبكر والعائلي.)
2. Who should consider this genetic test?
Snippet: Individuals with a strong family history of early‑onset atrial fibrillation or unexplained cardiomyopathy should consider this ABCC9 NGS test after genetic counseling.
This test is appropriate for patients with personal or family history of atrial fibrillation diagnosed before age 60, especially when multiple relatives are affected or cardiomyopathy is present. Genetic counseling is mandatory to assess inheritance patterns and implications.
(يُوصى بهذا التحليل للأشخاص الذين لديهم تاريخ عائلي قوي للرجفان الأذيني المبكر أو اعتلال عضلة القلب غير المفسر، بعد جلسة استشارة وراثية.)
3. How is the test performed and what does it involve?
Snippet: A simple blood sample is collected at your home by a certified phlebotomist, then NGS sequencing examines the entire ABCC9 coding region; results return in 3–4 weeks.
After a pre‑test genetic counseling session (via teleconsultation), our VIP mobile phlebotomy team arrives at your preferred location, collects a single blood tube, and transports it under strict cold‑chain protocols to our ISO‑certified lab. The DNA is extracted, enriched, and sequenced with coverage >99% of the gene. A comprehensive report is provided along with a post‑test clinical guidance call.
(تُسحب عينة دم بسيطة في المنزل بواسطة أخصائي معتمد، ثم يُحلل الحمض النووي بتقنية التسلسل الجيني المتقدم، وتصدر النتائج خلال 3-4 أسابيع مع استشارة طبية.)
ABCC9 Genetic – DHA/MOHAP Standardized. Facility License: 9834453. ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139). Follows UAE Federal Decree‑Law No. 41 of 2024, CDS Law 2026 (Minors), and UAE PDPL. Home Collection: 8 AM – 11 PM. Support: +971545488731.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians